Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Feb;39(2):529–532. doi: 10.1128/aac.39.2.529

Polymyxin B stimulates production of complement components and cytokines in human monocytes.

A K Høgåsen 1, T G Abrahamsen 1
PMCID: PMC162573  PMID: 7726527

Abstract

Polymyxin B (PmB), an agent often used to neutralize the effects of bacterial lipopolysaccharide (LPS), was shown to exert a dose-dependent stimulatory effect on the biosynthesis of C3, factor B, interleukin-6 (IL-6), and granulocyte-macrophage colony-stimulating factor (GM-CSF) in human monocytes. A low dose of PmB (1 to 5 micrograms/ml) efficiently suppressed the LPS-induced (1 or 100 ng/ml) production of IL-6, GM-CSF, and factor B, but not the C3 production induced by 100 ng of LPS per ml. A reduced level of GM-CSF may have contributed to the persisting high C3 concentrations and the apparent lack of LPS inhibition in the latter situation, since GM-CSF is an inhibitor of monocyte C3 biosynthesis.

Full Text

The Full Text of this article is available as a PDF (186.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin G., Alpert G., Caputo G. L., Baskin M., Parsonnet J., Gillis Z. A., Thompson C., Siber G. R., Fleisher G. R. Effect of polymyxin B on experimental shock from meningococcal and Escherichia coli endotoxins. J Infect Dis. 1991 Sep;164(3):542–549. doi: 10.1093/infdis/164.3.542. [DOI] [PubMed] [Google Scholar]
  2. Cleary J. D., Chapman S. W., Nolan R. L. Pharmacologic modulation of interleukin-1 expression by amphotericin B-stimulated human mononuclear cells. Antimicrob Agents Chemother. 1992 May;36(5):977–981. doi: 10.1128/aac.36.5.977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Damais C., Jupin C., Parant M., Chedid L. Induction of human interleukin-1 production by polymyxin B. J Immunol Methods. 1987 Jul 16;101(1):51–56. doi: 10.1016/0022-1759(87)90215-8. [DOI] [PubMed] [Google Scholar]
  4. Duff G. W., Atkins E. The inhibitory effect of polymyxin B on endotoxin-induced endogenous pyrogen production. J Immunol Methods. 1982 Aug 13;52(3):333–340. doi: 10.1016/0022-1759(82)90005-9. [DOI] [PubMed] [Google Scholar]
  5. Erroi A., Specchia G., Liso V., Colotta F., Bersani L., Polentarutti N., Chen Z. G., Allavena P., Mantovani A. Interleukin-1 and tumor necrosis factor production in acute non-lymphoid leukemia. Eur J Haematol. 1989 Jan;42(1):16–23. doi: 10.1111/j.1600-0609.1989.tb00241.x. [DOI] [PubMed] [Google Scholar]
  6. Fibbe W. E., Kluck P. M., Duinkerken N., Voogt P. J., Willemze R., Falkenburg J. H. Factors influencing release of granulocyte-macrophage colony-stimulating activity from human mononuclear phagocytes. Eur J Haematol. 1988 Oct;41(4):352–358. doi: 10.1111/j.1600-0609.1988.tb00209.x. [DOI] [PubMed] [Google Scholar]
  7. Flegel W. A., Rich I. N., Schilling M. L., Northoff H. Testing cell activation and cytokine release in serum-supplemented cultures: methodical note concerning polymyxin B. Eur J Haematol. 1989 Oct;43(4):359–360. doi: 10.1111/j.1600-0609.1989.tb00316.x. [DOI] [PubMed] [Google Scholar]
  8. Goodrum K. J. Stimulation of complement component C3 synthesis in macrophagelike cell lines by group B streptococci. Infect Immun. 1987 May;55(5):1101–1105. doi: 10.1128/iai.55.5.1101-1105.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hamilton A. O., Jones L., Morrison L., Whaley K. Modulation of monocyte complement synthesis by interferons. Biochem J. 1987 Mar 15;242(3):809–815. doi: 10.1042/bj2420809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hartung H. P., Hadding U. Synthesis of complement by macrophages and modulation of their functions through complement activation. Springer Semin Immunopathol. 1983;6(4):283–326. doi: 10.1007/BF02116277. [DOI] [PubMed] [Google Scholar]
  11. Høgåsen A. K., Abrahamsen T. G. Increased C3 production in human monocytes after stimulation with Candida albicans is suppressed by granulocyte-macrophage colony-stimulating factor. Infect Immun. 1993 May;61(5):1779–1785. doi: 10.1128/iai.61.5.1779-1785.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Høgåsen A. K., Hestdal K., Abrahamsen T. G. Granulocyte-macrophage colony-stimulating factor, but not macrophage colony-stimulating factor, suppresses basal and lipopolysaccharide-stimulated complement factor production in human monocytes. J Immunol. 1993 Sep 15;151(6):3215–3224. [PubMed] [Google Scholar]
  13. Morrison D. C., Jacobs D. M. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry. 1976 Oct;13(10):813–818. doi: 10.1016/0019-2791(76)90181-6. [DOI] [PubMed] [Google Scholar]
  14. Scholz W., McClurg M. R., Cardenas G. J., Smith M., Noonan D. J., Hugli T. E., Morgan E. L. C5a-mediated release of interleukin 6 by human monocytes. Clin Immunol Immunopathol. 1990 Nov;57(2):297–307. doi: 10.1016/0090-1229(90)90043-p. [DOI] [PubMed] [Google Scholar]
  15. Strunk R. C., Whitehead A. S., Cole F. S. Pretranslational regulation of the synthesis of the third component of complement in human mononuclear phagocytes by the lipid A portion of lipopolysaccharide. J Clin Invest. 1985 Sep;76(3):985–990. doi: 10.1172/JCI112099. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES